Susquehanna International Group’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.08M Buy
180,246
+121,470
+207% +$2.08M ﹤0.01% 1799
2025
Q1
$3.75M Sell
58,776
-9,127
-13% -$582K ﹤0.01% 1519
2024
Q4
$8.26M Sell
67,903
-42,272
-38% -$5.14M ﹤0.01% 813
2024
Q3
$13.8M Sell
110,175
-84,619
-43% -$10.6M ﹤0.01% 508
2024
Q2
$30.8M Sell
194,794
-86,903
-31% -$13.7M 0.01% 255
2024
Q1
$36.5M Buy
281,697
+156,096
+124% +$20.2M 0.01% 204
2023
Q4
$12.1M Sell
125,601
-14,740
-11% -$1.42M ﹤0.01% 603
2023
Q3
$17M Sell
140,341
-95,020
-40% -$11.5M ﹤0.01% 484
2023
Q2
$27M Buy
235,361
+95,534
+68% +$10.9M 0.01% 318
2023
Q1
$19.3M Buy
139,827
+31,880
+30% +$4.39M ﹤0.01% 470
2022
Q4
$14M Buy
107,947
+52,331
+94% +$6.78M ﹤0.01% 467
2022
Q3
$6.15M Buy
55,616
+52,824
+1,892% +$5.84M ﹤0.01% 720
2022
Q2
$209K Sell
2,792
-13,966
-83% -$1.05M ﹤0.01% 4504
2022
Q1
$1.31M Sell
16,758
-321,659
-95% -$25.1M ﹤0.01% 2502
2021
Q4
$30.5M Buy
338,417
+1,698
+0.5% +$153K ﹤0.01% 317
2021
Q3
$31.1M Buy
336,719
+136,888
+69% +$12.7M ﹤0.01% 340
2021
Q2
$15.5M Sell
199,831
-41,689
-17% -$3.24M ﹤0.01% 616
2021
Q1
$18M Buy
241,520
+97,927
+68% +$7.3M ﹤0.01% 511
2020
Q4
$24.5M Buy
143,593
+70,462
+96% +$12M ﹤0.01% 359
2020
Q3
$10.3M Buy
73,131
+44,255
+153% +$6.21M ﹤0.01% 511
2020
Q2
$4.63M Sell
28,876
-64,219
-69% -$10.3M ﹤0.01% 872
2020
Q1
$9.11M Sell
93,095
-85,834
-48% -$8.4M ﹤0.01% 442
2019
Q4
$23.1M Sell
178,929
-379,710
-68% -$49M 0.01% 270
2019
Q3
$42.1M Buy
558,639
+200,313
+56% +$15.1M 0.01% 134
2019
Q2
$54.4M Buy
358,326
+128,316
+56% +$19.5M 0.02% 115
2019
Q1
$27.4M Sell
230,010
-102,667
-31% -$12.2M 0.01% 133
2018
Q4
$36.3M Sell
332,677
-140,983
-30% -$15.4M 0.01% 101
2018
Q3
$76.5M Sell
473,660
-463,422
-49% -$74.8M 0.03% 74
2018
Q2
$124M Buy
937,082
+630,493
+206% +$83.3M 0.04% 58
2018
Q1
$22.7M Sell
306,589
-868,215
-74% -$64.3M 0.01% 177
2017
Q4
$65.4M Buy
1,174,804
+169,159
+17% +$9.41M 0.02% 77
2017
Q3
$45.6M Buy
1,005,645
+166,894
+20% +$7.57M 0.02% 90
2017
Q2
$28.3M Buy
838,751
+571,072
+213% +$19.3M 0.01% 138
2017
Q1
$7.92M Sell
267,679
-458,365
-63% -$13.6M ﹤0.01% 329
2016
Q4
$19.9M Buy
726,044
+695,658
+2,289% +$19.1M 0.01% 151
2016
Q3
$1.87M Sell
30,386
-519,576
-94% -$31.9M ﹤0.01% 982
2016
Q2
$10.5M Sell
549,962
-27,085
-5% -$517K 0.01% 220
2016
Q1
$11.3M Sell
577,047
-109,719
-16% -$2.14M 0.01% 303
2015
Q4
$26.5M Buy
686,766
+37,370
+6% +$1.44M 0.01% 199
2015
Q3
$20.9M Buy
649,396
+48,400
+8% +$1.55M 0.01% 273
2015
Q2
$18.3M Buy
600,996
+129,347
+27% +$3.94M 0.01% 353
2015
Q1
$6.26M Sell
471,649
-11,702
-2% -$155K ﹤0.01% 709
2014
Q4
$6.99M Buy
483,351
+66,558
+16% +$963K ﹤0.01% 760
2014
Q3
$8.79M Buy
416,793
+366,991
+737% +$7.74M ﹤0.01% 633
2014
Q2
$1.48M Sell
49,802
-384,993
-89% -$11.5M ﹤0.01% 2028
2014
Q1
$10.4M Buy
434,795
+18,449
+4% +$443K ﹤0.01% 541
2013
Q4
$8.48M Buy
416,346
+385,546
+1,252% +$7.85M ﹤0.01% 723
2013
Q3
$1.45M Sell
30,800
-559,177
-95% -$26.4M ﹤0.01% 1762
2013
Q2
$22.4M Buy
+589,977
New +$22.4M 0.01% 257